Find a Doctor or Practice Location

Medical School: University of Pennsylvania School of Medicine
Residency: Bronx Municipal Hospital - Albert Einstein College
Fellowship: Hospital of the University of Pennsylvania

American College of Physicians, Fellow, National American Federation for Clinical Research, National American Society for Blood and Marrow Transplantation, National American Society of Clinical Oncology, National American Society of Hematology, National Autologous Bone Marrow Transplant Registry (ABMTR/CIBMTR), National Bone Marrow Transplant Clinical Trials Network, National Eastern Cooperative Oncology Group, National Foundation for the Accreditation of Hematopoietic Cell Therapy, National International Myeloma Working Group, International Membership in External Advisory Committees, Endpoint Review Committees, and Data Safety and Monitoring Boards, International Membership in National Scientific Review Panels, National NCI Myeloma Steering Committee, National NIAID Hematopoietic Stem Cell Transplantation Data Safety Monitoring Board (HSCT DSMB), National

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.

Description of Research Expertise:

Clinical trials, Bone Marrow Transplant

Selected Publications:

Reshef R, Ganetsky A, Acosta EP, Blauser R, Crisalli L, McGraw J, Frey NV, Hexner Elizabeth O, Hoxie JA, Loren AW, Luger SM, Mangan J, Stadtmauer EA, Mick R, Vonderheide RH, Porter DL: Extended CCR5 Blockade for Graft-Versus-Host Disease Prophylaxis Improves Outcomes of Reduced Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation : 2018.

Ganetsky A, Han JH, Hughes ME, Babushok DV, Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Mangan JK, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL: Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America : 2018.

Micallef IN, Stiff PJ, Nademanee AP, Maziarz RT, Horwitz ME, Stadtmauer EA, Kaufman JL, McCarty JM, Vargo R, Cheverton PD, Struijs M, Bolwell B, DiPersio JF: Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 24 (6): 1187-1195,2018.

Crisalli LM, Hinkle JT, Walling CC, Sell M, Frey NV, Hexner EO, Loren AW, Luger SM, Stadtmauer EA, Porter DL, Reshef R: Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 24 (6): 1203-1208,2018.

Ganetsky A, Frey NV, Hexner EO, Loren AW, Gill SI, Luger SM, Mangan JK, Martin ME, Babushok DV, Drobyski WR, Smith J, Timlin C, Freyer CW, Stadtmauer EA, Porter DL: Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract. Bone marrow transplantation : 2018.

Garfall AL, Stadtmauer EA, Hwang WT, Lacey SF, Melenhorst Jan Joseph, Krevvata M, Carroll MP, Matsui WH, Wang Q, Dhodapkar MV, Dhodapkar K, Das R, Vogl DT, Weiss BM, Cohen AD, Mangan PA, Ayers EC, Nunez-Cruz S, Kulikovskaya I, Davis MM, Lamontagne A, Dengel K, Kerr Naseem Ds, Young RM, Siegel DL, Levine BL, Milone MC, Maus MV, June CH: Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI insight 3 (8): 2018.

Waxman AJ, Clasen S, Hwang Wei-Ting, Garfall A, Vogl DT, Carver J, O'Quinn R, Cohen AD, Stadtmauer EA, Ky B, Weiss BM: Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysis. JAMA oncology 4 (3): e174519,2018.

Holstein SA, Jung SH, Richardson PG, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Weisdorf DJ, Vij R, Moreb JS, Callander NS, Van Besien K, Gentile TG, Isola L, Maziarz RT, Bashey A, Landau H, Martin T, Qazilbash MH, Rodriguez C, McClune B, Schlossman RL, Smith SE, Hars V, Owzar K, Jiang C, Boyd M, Schultz C, Wilson M, Hari P, Pasquini MC, Horowitz MM, Shea TC, Devine SM, Linker C, Anderson KC, McCarthy PL: Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial. The Lancet. Haematology 4 (9): e431-e442,2017.

D'Souza A, Pasquini M, Logan B, Giralt S, Krishnan A, Antin J, Howard A, Goodman S, Qazilbash M, Knust K, Sahebi F, Weisdorf D, Vesole D, Stadtmauer EA, Maloney D, Hari P: Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study. British journal of haematology 178 (5): 816-819,2017.

Bair SM, Strelec L, Nagle SJ, Nasta SD, Landsburg DJ, Mato AR, Loren AW, Schuster SJ, Stadtmauer EA, Svoboda J: Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis. American journal of hematology 92 (9): 879-884,2017.

Penn Cancer Services